InvestorsHub Logo
Followers 15
Posts 1236
Boards Moderated 0
Alias Born 12/16/2020

Re: None

Wednesday, 08/02/2023 11:49:36 AM

Wednesday, August 02, 2023 11:49:36 AM

Post# of 426854
Here's a stock tip for all my fellow posters...... it's kind of a turnaround story...... it's a very small company that services a niche market where it targets the number one killer in the world called Cardiovascular disease. They only have one drug but it's FDA approved to reduce Triglycerides as well as CVD risk by 33% when taken with a statin. They have $313 million in cash and no debt. They were cash flow positive in there current quarter. They have exclusivity in the EU for approximately 10+ years and are in the infant stages of growing that market. In the US they have patents protecting the CVD indication but not the Triglyceride indication. They are not actively growing the market in the US as there is evidence of patent infringement for their CVD patents by generic companies selling into the lower Triglyceride market. They are maintaining market share of around 57% of the market in the US despite the competition and infringement from these generic drug manufacturers. This is not for the risk averse investor though as they recently underwent a board takeover from a highly successful activist investor. They have an entirely new Board of Directors and a new CEO. The new CEO comp plan is designed to pay him a handsome premium on 5,000,000 share if he get the price up to $15/sh or sell the company. This new management team unlike the previous team is slashing costs and focusing on profitability and the activist investor has the audacity to want to increase shareholder value for the current and future shareholders. The current share price sits at $ 1.19/sh so make sure that if this is something you are interested in and find to be a worthwhile investment risk that you buy the shares at these prices before telling your friends about it. Oh and the ticker symbol is AMRN. Please do your on DD though as all investments are not without risk.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News